首页> 美国卫生研究院文献>PLoS Pathogens >Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases
【2h】

Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases

机译:使用CXCR4特异性锌指核酸酶工程化抗HIV的人类CD4 + T细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

HIV-1 entry requires the cell surface expression of CD4 and either the CCR5 or CXCR4 coreceptors on host cells. Individuals homozygous for the ccr5Δ32 polymorphism do not express CCR5 and are protected from infection by CCR5-tropic (R5) virus strains. As an approach to inactivating CCR5, we introduced CCR5-specific zinc-finger nucleases into human CD4+ T cells prior to adoptive transfer, but the need to protect cells from virus strains that use CXCR4 (X4) in place of or in addition to CCR5 (R5X4) remains. Here we describe engineering a pair of zinc finger nucleases that, when introduced into human T cells, efficiently disrupt cxcr4 by cleavage and error-prone non-homologous DNA end-joining. The resulting cells proliferated normally and were resistant to infection by X4-tropic HIV-1 strains. CXCR4 could also be inactivated in ccr5Δ32 CD4+ T cells, and we show that such cells were resistant to all strains of HIV-1 tested. Loss of CXCR4 also provided protection from X4 HIV-1 in a humanized mouse model, though this protection was lost over time due to the emergence of R5-tropic viral mutants. These data suggest that CXCR4-specific ZFNs may prove useful in establishing resistance to CXCR4-tropic HIV for autologous transplant in HIV-infected individuals.
机译:HIV-1进入需要宿主细胞上CD4和CCR5或CXCR4共受体的细胞表面表达。 ccr5Δ32多态性纯合的个体不表达CCR5,并受到保护,免受CCR5-tropic(R5)病毒株感染。作为灭活CCR5的一种方法,我们在过继转移之前将CCR5特异性的锌指核酸酶引入人CD4 + T细胞中,但是有必要保护细胞免受使用CXCR4(X4)代替或除了CCR5的病毒株的侵害。 R5X4)仍然存在。在这里,我们描述了工程化一对锌指核酸酶,将其引入人T细胞后,可通过裂解和易于出错的非同源DNA末端连接有效破坏cxcr4。所得的细胞正常增殖,并且对X4-嗜性HIV-1菌株的感染具有抗性。 CXCR4也可以在ccr5Δ32CD4 + T细胞中失活,并且我们证明这种细胞对所有测试的HIV-1菌株均具有抗性。 CXCR4的丧失在人源化小鼠模型中也提供了针对X4 HIV-1的保护,尽管由于R5嗜性病毒突变体的出现,这种保护会随着时间的流逝而消失。这些数据表明,CXCR4特异性ZFN可能被证明可用于建立对CXCR4嗜性HIV的抗性,以用于HIV感染者的自体移植。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号